Vitenskapelig artikkel

• Jingzhou Zhang; Matthew Moll; Catherine L. Debban et al. (2026). Body Mass Index-related genetic factors and COPD imaging phenotypes. (ekstern lenke)
• Rune Nielsen; Ane Johannessen; Ernst Omenaas et al. (2011). Excessive costs of COPD in ever-smokers. A longitudinal community study. (ekstern lenke)
• Bjarte Gjerde; Per S. Bakke; Thor Ueland et al. (2012). The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. (ekstern lenke)
• Louise V. Wain; Nick Shrine; Maria Soler Artigas et al. (2017). Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. (ekstern lenke)
• Alexander G. Mathioudakis; Fekri Abroug; Alvar Agusti et al. (2022). ERS statement: A core outcome set for clinical trials evaluating the management of COPD exacerbations. (ekstern lenke)
• Peter J. Castaldi; Dawn L DeMeo; Craig P Hersh et al. (2011). Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. (ekstern lenke)
• Jacob Louis Marott; Truls Sylvan Ingebrigtsen; Yunus Çolak et al. (2023). Impact of the metabolic syndrome on cardiopulmonary morbidity and mortality in individuals with lung function impairment: a prospective cohort study of the Danish general population. (ekstern lenke)
• Marilyn G. Foreman; Xiangyang Kong; Dawn L DeMeo et al. (2011). Polymorphisms in surfactant protein D are associated with COPD. (ekstern lenke)
• Ane Aamli Gagnat; Miriam Gjerdevik; Stein Atle Lie et al. (2020). Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma. (ekstern lenke)
• Ernst Omenaas; Per Bakke; G Haukenes et al. (1995). Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. (ekstern lenke)
• W. Eduard; Ernst Omenaas; Per Bakke et al. (2004). Atopic and non-atopic asthma in a farming and a general population. (ekstern lenke)
• Tomas M. Eagan; Amund Gulsvik; Geir Egil Eide et al. (2004). Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. (ekstern lenke)
• Jan Brøgger; T Eagan; Geir Egil Eide et al. (2004). Bias in retrospective studies of trends in asthma incidence. (ekstern lenke)
• Jan Brøgger; Per Bakke; G.E. Eide et al. (2004). Trends in symptoms of obstructive lung disease in Norway. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1996). Serum house dust mite antibodies: Predictor of increased bronchial responsiveness in adults of a community. (ekstern lenke)
• Nazanin Zounemat Kermani; Kian Fan Chung; Giuseppe Macis et al. (2024). Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomics. (ekstern lenke)
• D.A. Enarson; S.M. Kennedy; D.L. Miller et al. (2004). Interpreting and reporting results. (ekstern lenke)
• Marianne Aanerud; Tomas Mikal Lind Eagan; Tore Wentzel-Larsen et al. (2007). Changes in Respiratory Symptoms and Health-Related Quality of Life. (ekstern lenke)
• Michael H. Cho; Nadia Boutaoui; Barbara J. Klanderman et al. (2010). Variants in FAM13A are associated with chronic obstructive pulmonary disease. (ekstern lenke)
• I. Welle; Geir Egil Eide; Per Bakke et al. (2004). Pulmonary gas exchange and educational level: a community study. (ekstern lenke)
• Thomas Halvorsen; Britt Torunn Skadberg; Geir Egil Eide et al. (2004). Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. (ekstern lenke)
• Per S. Bakke; Guohua H Zhu; Amund Gulsvik et al. (2011). Candidate genes for chronic obstructive pulmonary disease in two large data sets. (ekstern lenke)
• Tomas M. Eagan; Amund Gulsvik; Geir Egil Eide et al. (2004). The effect of educational level on the incidence of asthma and respiratory symptoms. (ekstern lenke)
• Per Bakke; M Taule; E Lille et al. (1997). Transcutaneous abdominal ultrasonography in the staging of lung cancer. (ekstern lenke)
• Amitabh Sharma; Maksim Kitsak; Michael H. Cho et al. (2018). Integration of Molecular Interactome and Targeted Interaction Analysis to Identify a COPD Disease Network Module. (ekstern lenke)
• Tamara Alonso Perez; Elena García Castillo; Julio Ancochea et al. (2020). Sex differences between women and men with COPD: A new analysis of the 3CIA study. (ekstern lenke)
• Solveig Tangedal; Rune Nielsen; Marianne Aanerud et al. (2019). Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. (ekstern lenke)
• Thomas Blix Grydeland; Paal Methlie; Per Bakke (2006). Opplæring av pasienter i riktig bruk av inhalasjonsmedisiner. (ekstern lenke)
• Einar Marius Hjellestad Martinsen; Tomas Mikal Eagan; Elise Orvedal Leiten et al. (2019). Motivation and response rates in bronchoscopy studies. (ekstern lenke)
• Per Bakke (1992). Allergiske sykdommer i Norge. Operative definisjoner, forekomst og risikofaktorer. (ekstern lenke)
• Phuwanat Sakornsakolpat; Meredith McCormack; Per S. Bakke et al. (2019). Genome-Wide Association Analysis of Single-Breath DlCO. (ekstern lenke)
• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2014). Physical activity and longitudinal change in 6-min walk distance in COPD patients. (ekstern lenke)
• Per Quist-Paulsen; Per Bakke; Frode Gallefoss (2006). Does smoking cessation improve quality of life in patients with coronary heart disease?. (ekstern lenke)
• Per S. Bakke; Eva Rönmark; Tomas Mikal Eagan et al. (2011). Recommendations for epidemiological studies on COPD. (ekstern lenke)
• Sharon M. Lutz; Michael H. Cho; Kendra Young et al. (2015). A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. (ekstern lenke)
• Michelle C. Williams; John T. Murchison; Lisa D. Edwards et al. (2014). Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. (ekstern lenke)
• N Le Moual; Per Bakke; H Kromhaut et al. (2000). Performance of population-specific job exposure-matrices (JEM). (ekstern lenke)
• Gunnar Husebø; Rune Nielsen; Jon Andrew Hardie et al. (2019). Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study. (ekstern lenke)
• Per Bakke; Valborg Baste; R. Hanoa et al. (1991). Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. (ekstern lenke)
• Gunnar Husebø; Esteban Gabazza; Corina D'Alessandro-Gabazza et al. (2020). Coagulation markers as predictors for clinical events in COPD. (ekstern lenke)
• Trude Duelien Skorge; Tomas Mikal Lind Eagan; Geir Egil Eide et al. (2009). Occupational exposure and incidence of respiratory disorders in a general population. (ekstern lenke)
• Tomas Mikal Eagan; Esteban C. Gabazza; Corina D'Alessandro-Gabazza et al. (2012). TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. (ekstern lenke)
• Phuwanat Sakornsakolpat; Dmitry Prokopenko; Maxime Lamontagne et al. (2019). Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. (ekstern lenke)
• Joost Brandsma; James P.R. Schofield; Xian Yang et al. (2023). Stratification of asthma by lipidomic profiling of induced sputum supernatant. (ekstern lenke)
• Thomas Halvorsen; Britt Torunn Skadberg; Geir Egil Eide et al. (2005). Assessment of lung volumes in children and adolescents: comparison of two plethysmographic techniques. (ekstern lenke)
• KE Lund; M Andersen; Per Bakke et al. (2000). Snakker helsepersonell med småbarnsforeldre om passiv røyking?. (ekstern lenke)
• B Lundbäck; Per Bakke; S Humerfelt et al. (2000). Nonpharmacological intervention in obstructive lung disease. (ekstern lenke)
• Marta Erdal; Ane Johannessen; Tomas Mikal Eagan et al. (2016). Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. (ekstern lenke)
• Michael Langballe Storebø; Tomas Mikal Eagan; Geir Egil Eide et al. (2016). Change in Pulmonary Diffusion Capacity in a General Population Sample over 9 Years. (ekstern lenke)
• Rosalia Emma; Aruna T. Bansal; Johan Kolmert et al. (2018). Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort. (ekstern lenke)
• Per Bakke; Valborg Baste; Amund Gulsvik (1991). Bronchial responsiveness in a Norwegian community. (ekstern lenke)
• Per Bakke; Geir Egil Eide; R. Hanoa et al. (1991). Occupational airborn exposure and respiratory disorders in a general population of Norway. (ekstern lenke)
• Mateusz Siedlinski; Michael H. Cho; Per S. Bakke et al. (2011). Genome-wide association study of smoking behaviours in patients with COPD. (ekstern lenke)
• KE Lund; M Andersen; Per Bakke et al. (2000). Snakker helsepersonell med småbarnsforeldre om passiv røyking?. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1996). Serum respiratory virus antibodies: Predictor of reduced one second forced expiratory volume in Norwegian adults. (ekstern lenke)
• Susanne Hernes; Egil Hagen; Ståle Tofteland et al. (2010). Transthoracic fine-needle aspiration in the aetiological diagnosis of communityacquired pneumonia. (ekstern lenke)
• Rune Nielsen; Yaxin Xue; Inge Jonassen et al. (2021). Repeated bronchoscopy in health and obstructive lung disease: is the airway microbiome stable?. (ekstern lenke)
• Karl Erik Lund; Per S. Bakke; Frode Gallefoss et al. (2000). I hvor stor grad snakker helsepersonell med småbarnsforeldre om passiv røyking?. (ekstern lenke)
• Tomas Mikal Lind Eagan; Thor Ueland; Peter D. Wagner et al. (2010). Systemic inflammatory markers in chronic obstructive pulmonary disease – results from the Bergen COPD Cohort Study. (ekstern lenke)
• Tomas Mikal Lind Eagan; Pål Aukrust; Per S. Bakke et al. (2009). Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. (ekstern lenke)
• Jason Z. Liu; Federica Tozzi; Dawn M. Waterworth et al. (2010). Meta-analysis and imputation refines the association of 15q25 with smoking quantity. (ekstern lenke)
• Anneloes L. van Rijn; Sander van Boheemen; Igor Sidorov et al. (2019). The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease. (ekstern lenke)
• Frode Gallefoss; Per Bakke (2000). Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. (ekstern lenke)
• Per Bakke; Amund Gulsvik (2000). Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. (ekstern lenke)
• S Humerfelt; Per Bakke; Ernst Omenaas et al. (2000). Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. (ekstern lenke)
• C Janson; Per Bakke; T Haahtela et al. (2000). Obstructive lung disease in patients within the hospital in the Nordic countries. (ekstern lenke)
• Per Bakke; K Katsouyanni; L Carrozzi (2000). Study design. (ekstern lenke)
• Frode Gallefoss; Per Bakke (2000). Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. (ekstern lenke)
• Per Bakke; Amund Gulsvik (2000). Et forsvarlig blikk på bupropion. (ekstern lenke)
• Lan Ai Kieu Le; Ane Johannessen; Jon Andrew Hardie et al. (2019). Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. (ekstern lenke)
• Anne M van der Does; Marieke Heijink; Oleg A. Mayboroda et al. (2019). Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls. (ekstern lenke)
• Amund Gulsvik; Per Bakke (2000). Prevention of death from asthma. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Amund Gulsvik (2000). Comparison of respiratory symptoms questionnaires. (ekstern lenke)
• Roy Meys; Frits M.E. Franssen; Alex J. Van ‘t Hul et al. (2024). Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED. (ekstern lenke)
• Frode Gallefoss; Per Bakke; IJH Wang et al. (2000). Smoking status, disease duration, and educational level in females, are related to asthma school participation. (ekstern lenke)
• Guohua Zhu; Alvar Agusti; Amund Gulsvik et al. (2009). CTLA4 gene polymorphisms are associated with chronic bronchitis. (ekstern lenke)
• Tor Hatlestad Qvale; Anette Storstein; Kibret Yimer Mazengia et al. (2014). Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease. (ekstern lenke)
• Thomas Grydeland; Asger Dirksen; Harvey O. Coxson et al. (2009). Quantitative CT Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms. (ekstern lenke)
• Xiangyang Kong; Michael H. Cho; Wayne Anderson et al. (2011). Genome-wide Association Study Identifies BICD1 as a Susceptibility Gene for Emphysema. (ekstern lenke)
• Rune Grønseth; Ingvild Haaland; Harald G Wiker et al. (2014). The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences. (ekstern lenke)
• Jin Hwa Lee; Michael H. Cho; Craig P Hersh et al. (2014). Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. (ekstern lenke)
• M Skold; P Bakke; Johny Kongerud et al. (2005). Scandinavian COPD research symposium. (ekstern lenke)
• Per Bakke; Amund Gulsvik (2000). Et forsvarlig blikk på bupropion. (ekstern lenke)
• Jan Christian Brøgger; Vidar Martin Steen; Hans Geir Eiken et al. (2006). Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. (ekstern lenke)
• Bartolome R. Celli; Nicholas Locantore; Julie Yates et al. (2012). Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. (ekstern lenke)
• Ane Aamli Gagnat; Amund Gulsvik; Per S. Bakke et al. (2019). Comparison of two lung cancer screening scores among patients with chronic obstructive pulmonary disease: A community study. (ekstern lenke)
• Thomas Blix Grydeland; Einar Thorsen; Asger Dirksen et al. (2011). Quantitative CT measures of emphysema and airway wall thickness are related to DLCO. (ekstern lenke)
• Erica P.A. Rutten; Peter M.A. Calverley; Richard Casaburi et al. (2013). Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?. (ekstern lenke)
• Amund Gulsvik; Per Bakke; S. Humerfelt et al. (1991). Measurements of respiration symptoms and sample size to detect a given difference between treatment groups in obstructive lung disease. (ekstern lenke)
• Susanne Hernes; Hanne Quarsten; Runar Hamre et al. (2013). A comparison of nasopharyngeal and oropharyngeal swabbing for the detection of influenza virus by real-time PCR. (ekstern lenke)
• Joy Miller; Lisa D. Edwards; Alvar Agusti et al. (2013). Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2002). Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. (ekstern lenke)
• James P.R. Schofield; Dominic Burg; Ben Nicholas et al. (2019). Stratification of asthma phenotypes by airway proteomic signatures. (ekstern lenke)
• Ane Johannessen; Ernst Omenaas; Geir Egil Eide et al. (2007). Feasible and simple exclusion criteria for pulmonary reference populations. (ekstern lenke)
• Ane Johannessen; Sverre Lehmann; Ernst Omenaas et al. (2006). Post-bronchodilator spirometry reference values in adults and implications for disease management. (ekstern lenke)
• Heidi Catrine Berg Rolke; Per S. Bakke; Frode Gallefoss (2009). Relationships between hand-rolled cigarettes and primary lung cancer: A Norwegian experience. (ekstern lenke)
• Megan Hardin; Michael H. Cho; Sunita Sharma et al. (2017). Sex-based genetic association study identifies celsr1 as a possible chronic obstructive pulmonary disease risk locus among women. (ekstern lenke)
• Gunnar Reksten Husebø; Per S. Bakke; Marianne Aanerud et al. (2014). Predictors of exacerbations in chronic obstructive pulmonary disease - results from the Bergen COPD Cohort Study. (ekstern lenke)
• Adel Boueiz; Sharon M Lutz; Michael H. Cho et al. (2017). Genome-wide association study of the genetic determinants of emphysema distribution. (ekstern lenke)
• Thomas Grydeland; A Dirksen; HO Coxson et al. (2009). Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. (ekstern lenke)
• Douglas J. Conrad; Barbara A. Bailey; Jon Andrew Hardie et al. (2017). Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. (ekstern lenke)
• Sarah Wilke; Paul W. Jones; Hana X. Müllerová et al. (2015). One-year change in health status and subsequent outcomes in COPD. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1998). Immunoglobulin E, viral antibodies and obstructive lung disease in adults. The relation between antibody level in serum, lung function and non-specific bronchial reactivity. (ekstern lenke)
• Ane Johannessen; Ernst Omenaas; Per Bakke et al. (2005). Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. (ekstern lenke)
• Marianne Voll-Aanerud; Tomas M.L. Eagan; Tore Wentzel-Larsen et al. (2008). Asthma and health-related quality of life - effect of adjusting for potential confounders. (ekstern lenke)
• Y. Li; X. Xiao; Y. Han et al. (2017). Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. (ekstern lenke)
• Ernst Omenaas; Ronald Dahl; Per Bakke et al. (2006). Nordic physician's management of asthma and chronic obstructive pulmonary disease. (ekstern lenke)
• Jon Andrew Hardie; William M. Vollmer; A. Sonia Buist et al. (2005). Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. (ekstern lenke)
• Peter J. Lipman; Michael H. Cho; Per S. Bakke et al. (2011). On the follow-up of genome-wide association studies: An overall tst for the most promising SNPs. (ekstern lenke)
• Andreas Thelle; Miriam Gjerdevik; Malcolm Sue-Chu et al. (2017). Randomised comparison of needle aspiration and chest tube drainage in spontaneous pneumothorax. (ekstern lenke)
• Matthew Moll; Phuwanat Sakornsakolpat; Nick Shrine et al. (2020). Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts. (ekstern lenke)
• Godfrey Etokebe; Shanbeh Zienolddiny; Zeljko Kupanovac et al. (2015). Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations. (ekstern lenke)
• Per Bakke; Valborg Baste; R. Hanoa et al. (1992). Occupational airborne exposure of the general population of a Norwegian county. (ekstern lenke)
• Jon Andrew Hardie; Per Bakke; Odd Mørkve (2004). Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. (ekstern lenke)
• Mario Olivieri; Maria C. Mirabelli; Estel Plana et al. (2010). Healthy hire effect, job selection and inhalation exposure among young adults with asthma. (ekstern lenke)
• Inga Cecilie Sørheim; Per S. Bakke; Amund Gulsvik et al. (2010). alpha(1)-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts. (ekstern lenke)
• Xiaobo Zhou; Weiliang Qiu; J. Fah Sathirapongsasuti et al. (2013). Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. (ekstern lenke)
• Guohua Zhu; Liling Warren; Jennifer Aponte et al. (2007). The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. (ekstern lenke)
• Bernt Bøgvald Aarli; Tomas Mikal Eagan; Ivar Ellingsen et al. (2013). Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. (ekstern lenke)
• Johan Kolmert; Cristina Gómez; David Balgoma et al. (2021). Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study. (ekstern lenke)
• Louise Jeanette Pauline Persson; Marianne Aanerud; Pieter Sicco Hiemstra et al. (2015). Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD. (ekstern lenke)
• Maria Sparreman Mikus; Johan Kolmert; Lars I. Andersson et al. (2022). Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation. (ekstern lenke)
• Ema Rastoder; Pradeesh Sivapalan; Josefin Eklöf et al. (2023). Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients. (ekstern lenke)
• Bernt Bøgvald Aarli; Peter M.A. Calverley; Robert L. Jensen et al. (2017). The association of tidal EFL with exercise performance, exacerbations, and death in COPD. (ekstern lenke)
• Marianne Voll-Aanerud; Tomas Mikal Lind Eagan; Tore Wentzel-Larsen et al. (2008). Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. (ekstern lenke)
• Gunnar Husebø; Rune Grønseth; Lorena Lerner et al. (2017). Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD. (ekstern lenke)
• Diane Lefaudeux; Bertrand De Meulder; Matthew J. Loza et al. (2017). U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. (ekstern lenke)
• Sverre Lehmann; Per S. Bakke; Geir Egil Eide et al. (2008). Clinical data discriminating between adults with positive and negative results on bronchodilator testing. (ekstern lenke)
• Eirunn Waatevik Saure; Tomas Mikal Eagan; Robert Leroy Jensen et al. (2012). Explained variance for blood gases in a population with COPD. (ekstern lenke)
• Elise Orvedal Leiten; Tomas Mikal Eagan; Einar Marius Hjellestad Martinsen et al. (2020). Complications and discomfort after research bronchoscopy in the MicroCOPD study. (ekstern lenke)
• Tomas Mikal Lind Eagan; Jan Kristian Damås; Thor Ueland et al. (2010). Neutrophil Gelatinase-Associated Lipocalin A Biomarker in COPD. (ekstern lenke)
• Stephen I. Rennard; Nicholas Locantore; Bruno Delafont et al. (2015). Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. (ekstern lenke)
• Sverre Lehmann; Per Bakke; Geir Egil Eide et al. (2007). Bronchodilator response to adrenergic (beta) (2)-agonists: Relationship to symptoms in an adult community. (ekstern lenke)
• Ernst Omenaas; Said Elsayed; Per Bakke et al. (1994). Total and specific immunoglobulin E-levels in a general adult population. Relationship to sex, age and environmental factors. (ekstern lenke)
• Alvar Agusti; Lisa D. Edwards; Stephen I Rennard et al. (2012). Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. (ekstern lenke)
• Jemma B. Wilk; NRG Shrine; LR Loehr et al. (2012). Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. (ekstern lenke)
• Trude Duelien Skorge; Tomas M.L. Eagan; Geir Egil Eide et al. (2007). Exposure to environmental tobacco smoke in a general population. (ekstern lenke)
• Ane Johannessen; Roy Miodini Nilsen; Michael Langballe Storebø et al. (2013). Comparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalization. (ekstern lenke)
• Jon Andrew Hardie; Per Bakke; Odd Mørkve (2003). Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. (ekstern lenke)
• Josiah E. Radder; Alyssa D. Gregory; Adriana S. Leme et al. (2017). Variable susceptibility to cigarette smoke-induced emphysema in 34 inbred strains of mice implicates Abi3bp in emphysema susceptibility. (ekstern lenke)
• T.E. Thorgeirsson; D.F. Gudbjartsson; P. Sulem et al. (2013). A common biological basis of obesity and nicotine addiction. (ekstern lenke)
• Michael H. Cho; Peter J. Castaldi; Emily S. Wan et al. (2012). A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. (ekstern lenke)
• Xuemei Ji; Semanti Mukherjee; Maria Teresa Landi et al. (2020). Protein-altering germline mutations implicate novel genes related to lung cancer development. (ekstern lenke)
• Vasileios Andrianopoulos; Bartolomé R. Celli; Frits M.E. Franssen et al. (2016). Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study. (ekstern lenke)
• Per Bakke; Amund Gulsvik; Geir Egil Eide (1990). Hayfever, eczema and urticaria in south-west Norway. Lifetime prevalences and association with sex, age, occupational airborne exposures and respiratory symptoms. (ekstern lenke)
• Ane Johannessen; Trude Duelien Skorge; Matteo Bottai et al. (2013). Mortality by level of emphysema and airway wall thickness. (ekstern lenke)
• Per S. Bakke (2008). Designing studies for diagnostic tests. (ekstern lenke)
• Lystra P. Hayden; Brian D. Hobbs; Robert Busch et al. (2023). X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study. (ekstern lenke)
• John Brehm; Koichi Hagiwara; Yohannes Tesfaigzi et al. (2011). Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. (ekstern lenke)
• Robert Busch; Brian D. Hobbs; Jin Zhou et al. (2017). Genetic association and risk scores in a chronic obstructive pulmonary disease meta-analysis of 16,707 subjects. (ekstern lenke)
• Per S. Bakke; Kristian Jong Høines (2019). Legemidler mot kols. (ekstern lenke)
• Per Bakke; Amund Gulsvik; R. Hanoa et al. (1990). Smoking habits and lifetime occupational exposure to gases or dusts, including asbestos and quartz, in a Norwegian community. (ekstern lenke)
• Per Bakke; Amund Gulsvik; Peer Kåre Lilleng et al. (1990). Postal survey on airborne occupational exposure and respiratory disorders in Norway. Causes and consequences of non-response. (ekstern lenke)
• Petter Quist-Paulsen; Stian Lydersen; Per Bakke et al. (2006). Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. (ekstern lenke)
• Kia Minna Hynninen; Ståle Pallesen; Jon Andrew Hardie et al. (2013). Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. (ekstern lenke)
• Ruihua Hou; Gang Ye; Xiaojing Cheng et al. (2023). The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts. (ekstern lenke)
• Rune Nielsen; Ane Johannessen; Hege Marie Schnelle et al. (2008). Repeatability of health economic data in COPD. (ekstern lenke)
• Deog Kyeom Kim; Michael H. Cho; Craig P Hersh et al. (2012). Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. (ekstern lenke)
• Tomas Mikal Eagan; Jon Andrew Hardie; Åsne Jul-Larsen et al. (2016). Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. (ekstern lenke)
• Weiliang Qiu; Michael H. Cho; John H. Riley et al. (2011). Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease. (ekstern lenke)
• Jørgen Vestbo; Lisa D. Edwards; Paul D. Scanlon et al. (2011). Changes in forced expiratory volume in 1 second over time in COPD. (ekstern lenke)
• Emily S. Wan; Michael H. Cho; Nadia Boutaoui et al. (2011). Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease. (ekstern lenke)
• Thomas Grydeland; Asger Dirksen; Harvey O. Coxson et al. (2010). Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. (ekstern lenke)
• Jin Hwa Lee; Merry-Lynn N. McDonald; Michael H. Cho et al. (2014). DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease. (ekstern lenke)
• Akkelies E. Dijkstra; H. Marike Boezen; Maarten Van Den Berge et al. (2015). Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. (ekstern lenke)
• Fahad H. Alahmadi; Andrew J. Simpson; Cristina Gomez et al. (2021). Medication Adherence in Patients With Severe Asthma Prescribed Oral Corticosteroids in the U-BIOPRED Cohort. (ekstern lenke)
• Louise Jeanette Pauline Persson; Marianne Aanerud; Jon Andrew Hardie et al. (2017). Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. (ekstern lenke)
• K Tariq; James P.R. Schofield; BL Nicholas et al. (2019). Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma. (ekstern lenke)
• Marc Vila; Alvar Agustí; Jørgen Vestbo et al. (2025). Contrasting the clinical and biological characteristics of young and old COPD patients. (ekstern lenke)
• Rosa Faner; Guillaume Noell; Joan Ramon Badia et al. (2018). Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort. (ekstern lenke)
• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2014). Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients. (ekstern lenke)
• Bente Frisk; Jon Andrew Hardie; Birgitte Espehaug et al. (2015). Peak oxygen uptake and breathing pattern in COPD patients - a four-year longitudinal study. (ekstern lenke)
• Miriam Gjerdevik; Thomas Blix Grydeland; George R. Washko et al. (2015). The relationship of educational attainment with pulmonary emphysema and airway wall thickness. (ekstern lenke)
• Christina Due Svendsen; Karel Kier-Jan Kuiper; Kristoffer Ostridge et al. (2022). Factors associated with coronary heart disease in COPD patients and controls. (ekstern lenke)
• Dandi D. Qiao; Michael H. Cho; Heide Fier et al. (2014). On the simultaneous association analysis of large genomic regions: a massive multi-locus association test. (ekstern lenke)
• J Lotvall; Per S. Bakke; Leif Bjermer et al. (2012). Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. (ekstern lenke)
• Amund Gulsvik; Sjur Humerfelt; Per S. Bakke et al. (2008). Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. (ekstern lenke)
• Marianne Voll-Aanerud; Tomas Mikal Lind Eagan; Estel Plana et al. (2010). Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. (ekstern lenke)
• Merry-Lynn N. McDonald; Michael H. Cho; Inga Cecilie Sørheim et al. (2014). Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. (ekstern lenke)
• Craig P Hersh; Sreekumar G Pillai; Guohua H Zhu et al. (2010). Multistudy Fine Mapping of Chromosome 2q Identifies XRCC5 as a Chronic Obstructive Pulmonary Disease Susceptibility Gene. (ekstern lenke)
• Marie Wåtevik; Bente Frisk; Francisco Gomez Real et al. (2021). CT-defined emphysema in COPD patients and risk for change in desaturation status in 6-min walk test. (ekstern lenke)
• Merry-Lynn Noelle McDonald; Manuel Mattheisen; Michael H. Cho et al. (2014). Beyond GWAS in COPD: Probing the landscape between gene-set associations, genome-wide associations and protein-protein interaction networks. (ekstern lenke)
• Per Bakke (2003). Factors affecting growth of FEV1. (ekstern lenke)
• Amund Gulsvik; T Tosteson; Per Bakke et al. (2001). Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. (ekstern lenke)
• Marie Johanne Wåtevik; Bente Frisk; Francisco Gomez Real et al. (2020). One Year Change in 6-Minute Walk Test Outcomes is Associated with COPD Prognosis. (ekstern lenke)
• Joost Brandsma; Victoria M. Goss; Xian Yang et al. (2018). Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers. (ekstern lenke)
• Ane Johannessen; Ernst Omenaas; Per Bakke et al. (2005). Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. (ekstern lenke)
• F. Gallefoss; Per Bakke (2003). Does smoking affect the outcome of patient education and self-management in asthmatics?. (ekstern lenke)
• Frode Gallefoss; Per Bakke (2001). Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial. (ekstern lenke)
• Per Bakke; Rolf Hanoa; Amund Gulsvik (2001). Relationship of occupational exposure to respiratory symptoms and asthma in a general population sample – self-reported versus interview based exposure data. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1996). Associations of forced expiratory volume in one second to serum total IgE and respiratory virus antibodies in subexamples of a general population. (ekstern lenke)
• B Lundbäck; L Carrozzi; Per Bakke et al. (2001). Bronchitic symptoms and their relation to FEV1 in Italy, Sweden and Norway. (ekstern lenke)
• N Le Moual; Per Bakke; H Kromhout et al. (2001). Relationship between occupational exposure, estimated by two job-exposure matrices, and lung function in French, Dutch, and Norwegian community studies. (ekstern lenke)
• Elin Tollefsen; Amund Gulsvik; Per S. Bakke et al. (2009). Prevalens av hjemmerespiratorbehandling i Norge. (ekstern lenke)
• Marta Erdal; Ane Johannessen; Per S. Bakke et al. (2020). Incremental costs of COPD exacerbations in GOLD stage 2+ COPD in ever-smokers of a general population. (ekstern lenke)
• Anne Edvardsen; Aina Akerø; Jon Andrew Hardie et al. (2011). High prevalence of respiratory symptoms during air travel in patients with COPD. (ekstern lenke)
• Ida Welle; Per Bakke; Geir Egil Eide et al. (2001). Increased circulating levels of alpha-1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs. (ekstern lenke)
• Amund Gulsvik; LA Beckett; Per Bakke et al. (2001). Standardized submaximal exercise testing in never smokers: A normative study. (ekstern lenke)
• Stacey N. Reinke; Shama Naz; Romanas Chaleckis et al. (2022). Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. (ekstern lenke)
• Jingzhou Zhang; Matthew Moll; Brian D. Hobbs et al. (2024). Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease. (ekstern lenke)
• Michael H. Cho; Peter J. Castaldi; Craig P. Hersh et al. (2015). A genome-wide association study of emphysema and airway quantitative imaging phenotypes. (ekstern lenke)
• B Lundbäck; Per Bakke; S Humerfelt et al. (2000). Nonpharmacological intervention in obstructive lung disease. (ekstern lenke)
• N Le Moual; Per Bakke; H Kromhaut et al. (2000). Performance of population-specific Job exposure-matrices (JEM). (ekstern lenke)
• Frode Gallefoss; Per Bakke (2000). Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. (ekstern lenke)
• S Humerfelt; Per Bakke; Ernst Omenaas et al. (2000). Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. (ekstern lenke)
• C Janson; Per Bakke; T Haahtela et al. (2000). Obstructive lung disease in patients within the hospital in the Nordic countries. (ekstern lenke)
• Frode Gallefoss; Per Bakke; IJH Wang et al. (2000). Smoking status, disease duration, and educational level in females, are related to asthma school participation. (ekstern lenke)
• Frode Gallefoss; Per Bakke (2000). Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. (ekstern lenke)
• Hana Mullerova; Diego J Maselli; Nicholas Locantore et al. (2015). Hospitalized exacerbations of COPD: Risk factors and outcomes in the ECLIPSE cohort. (ekstern lenke)
• Joan B. Soriano; Bernd Lamprecht; Ana S. Ramírez et al. (2015). Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data. (ekstern lenke)
• Alvar Agusti; Lisa D. Edwards; Bartolomé Celli et al. (2013). Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. (ekstern lenke)
• Louise V. Wain; Nick Shrine; Suzanne Miller et al. (2015). Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): A genetic association study in UK Biobank. (ekstern lenke)
• Pierre-Régis Burgel; Jean-Louis Paillasseur; Wim Janssens et al. (2017). A simple algorithm for the identification of clinical COPD phenotypes. (ekstern lenke)
• Alexander G. Mathioudakis; Fekri Abroug; Alvar Agusti et al. (2020). Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: The cosaecopd ers task force study protocol. (ekstern lenke)
• Mateusz Siedlinski; Dustin Tingley; Peter J. Lipman et al. (2013). Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. (ekstern lenke)
• Marie Johanne Waatevik; Trude Duelien Skorge; Ernst Omenaas et al. (2013). Increased prevalence of chronic obstructive pulmonary disease in a general population. (ekstern lenke)
• Per Bakke; Amund Gulsvik (2000). Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. (ekstern lenke)
• JC Brøgger; Per Bakke; Amund Gulsvik (2000). Comparison of respiratory symptoms questionaires. (ekstern lenke)
• Xuemei Ji; Yohan Bossé; Maria Teresa Landi et al. (2018). Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. (ekstern lenke)
• Amund Gulsvik; Per Bakke (2000). Prevention of death from asthma. (ekstern lenke)
• J Brogger; P Bakke; Geir Egil Eide et al. (2004). Trends in symptoms of obstructive lung disease in Norway. (ekstern lenke)
• Susanne Hernes; Egil Hagen; Hanne Quarsten et al. (2014). No impact of early real-time PCR screening for respiratory viruses on length of stay and use of antibiotics in elderly patients hospitalized with symptoms of a respiratory tract infection in a single center in Norway. (ekstern lenke)
• Michael I. Polkey; Martijn A. Spruit; Lisa D. Edwards et al. (2013). Six-minute-walk test in chronic obstructive pulmonary disease minimal clinically important difference for death or hospitalization. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1995). Total serum IgE and FEV%b by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1995). Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Gunnar Haukenes et al. (1995). Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. (ekstern lenke)
• Ane Johannessen; Per S. Bakke; Jon Andrew Hardie et al. (2012). Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults. (ekstern lenke)
• Arnulf Langhammer; Ane Johannessen; Turid Lingaas Holmen et al. (2016). Global lung function initiative 2012 reference equations for spirometry in the Norwegian population. (ekstern lenke)
• Marie Johanne Waatevik; Ane Johannessen; Jon Andrew Hardie et al. (2012). Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. (ekstern lenke)
• Jessica D. Gereige; Hanfei Xu; Victor E. Ortega et al. (2022). A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts. (ekstern lenke)
• Eirunn Waatevik Saure; Tomas Mikal Eagan; Robert Leroy Jensen et al. (2014). Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up. (ekstern lenke)
• James D McKay; Rayjean J Hung; Younghun Han et al. (2017). Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. (ekstern lenke)
• Vegard Nilsen; Per S. Bakke; Gudrun-Elin Rohde et al. (2014). Predictors of health-related quality of life changes after lifestyle intervention in persons at risk of type 2 diabetes mellitus. (ekstern lenke)
• Susanne Hernes; Hanne Quarsten; Egil Hagen et al. (2011). Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs. (ekstern lenke)
• Bartolome Celli; Nicholas Locantore; Julie C. Yates et al. (2021). Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort. (ekstern lenke)
• Nick Shrine; Abril G. Izquierdo; Jing Chen et al. (2023). Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk. (ekstern lenke)
• Sverre Lehmann; Per Bakke; Geir Egil Eide et al. (2006). Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta(2)-agonist. (ekstern lenke)
• B. Lundbäck; Amund Gulsvik; M. Albers et al. (2003). Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2003). Long-term changes in adult asthma prevalence. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2003). Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Said Elsayed et al. (1994). Total and specific serum IgE levels in adults: relationship to sex, age and environemental factors. (ekstern lenke)
• Marianne Aanerud; Eirunn Waatevik Saure; Marta Benet et al. (2015). Serial measurements of arterial oxygen tension are associated with mortality in COPD. (ekstern lenke)
• Jan Brøgger; Per Bakke; Geir Egil Eide et al. (1999). Comparison between two respiratory symptomquestionnaires, by sex and smoking habits. (ekstern lenke)
• Geir Egil Eide; O Gefeller; M Land et al. (1999). New epidemiological interpretations of the average attributable fraction from a game theoretical perspective. (ekstern lenke)
• Tomas Eagan; Per Bakke; Geir Egil Eide et al. (1999). The association of sex, age and smoking to respiratory symptoms in a longitudinal study in western Norway. (ekstern lenke)
• Ida Welle; Per Bakke; Geir Egil Eide et al. (1999). Relationship between two biological inflammatory markers and single-breath transfer factor for carbon monoxide (TLCO) in a general population sample. (ekstern lenke)
• Ida Welle; Geir Egil Eide; Per Bakke et al. (1998). Applicability of the single breath carbon monoxide diffusing capacity in a Norwegian community study. (ekstern lenke)
• Amund Gulsvik; Jan Brøgger; Per Bakke et al. (1999). Asthma and wheezing are increasing in repeated community surveys of adults. (ekstern lenke)
• Rune Grønseth; Christine Drengenes; Harald G Wiker et al. (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. (ekstern lenke)
• Ida Welle; Geir Egil Eide; Per Bakke et al. (1999). Acute hospital treatment of obstructive lung disease in western Norway. (ekstern lenke)
• Megan E. Hardin; Michael Hyosang Cho; Merry-Lynn Noelle McDonald et al. (2016). A genome-wide analysis of the response to inhaled β 2-agonists in chronic obstructive pulmonary disease. (ekstern lenke)
• Michael H. Cho; Merry-Lynn N. McDonald; Xiaobo Zhou et al. (2014). Risk loci for chronic obstructive pulmonary disease: A genome-wide association study and meta-analysis. (ekstern lenke)
• Ane Johannessen; Tomas Mikal Lind Eagan; Ernst Omenaas et al. (2010). Socioeconomic risk factors for lung function decline in a general population. (ekstern lenke)
• Minna Hynninen; Nina Bjerke; Ståle Pallesen et al. (2010). A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. (ekstern lenke)
• Per Bakke; Frode Gallefoss; ME Gilja et al. (1998). Medikamentvaner og kunnskap om egen sykdom blant pasienter med obstruktiv lungesykdom. (ekstern lenke)
• Amund Gulsvik; Per Bakke; Å Andersen et al. (1998). Hvorfor øker forekomsten av astma i Norge?. (ekstern lenke)
• Ida Welle; Per Bakke; Geir Egil Eide et al. (1998). Serum inflammatory markers and level of carbon monoxide diffusion capacity in a general population sample. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1996). Serum house dust mite antibodies: Predictor of increased bronchial responsiveness in adults of a community. (ekstern lenke)
• Jan Brøgger; Wenche Nystad; Inger Cappelen et al. (2008). No increase in response rate by adding a web response option to a postal population survey: A randomized trial. (ekstern lenke)
• Elena García Castillo; Tamara Alonso Pérez; Julio Ancochea et al. (2020). Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data. (ekstern lenke)
• Elise Orvedal Leiten; Rune Nielsen; Harald Gotten Wiker et al. (2020). The airway microbiota and exacerbations of COPD. (ekstern lenke)
• Tomas Eagan; Per Bakke; Ida Welle et al. (1999). Incidence and remission rates of respiratory symptoms by sex, age and smoking in a Norwegian community during twelve years. (ekstern lenke)
• Heidi Catrine Berg Rolke; Per Bakke; Frode Gallefoss (2007). Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway. (ekstern lenke)
• AH Aamodt; Per Bakke; Amund Gulsvik (1999). Reproducibility of indoor environment characteristics obtained in a walk through questionaire. A pilot study. (ekstern lenke)
• Jan Brøgger; Per Bakke; S Opdahl et al. (1999). Decreasing response to respiratory disease surveys. (ekstern lenke)
• O Fondenes; Ernst Omenaas; Per Bakke et al. (1999). The risks of snoring and day-time hypersomnolence in a general Norwegian population. (ekstern lenke)
• Paul Albert; Alvar Agusti; Lisa D. Edwards et al. (2012). Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. (ekstern lenke)
• Rune Nielsen; Ane Johannessen; Per S. Bakke et al. (2009). Aspects of healthcare utilisation in self-reported obstructive lung disease. (ekstern lenke)
• Farzian Aminuddin; Tillie-Louise Hackett; Dorota Stefanowicz et al. (2013). Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. (ekstern lenke)
• Beniamino Guerra; Sarah R. Haile; Bernd Lamprecht et al. (2018). Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease. (ekstern lenke)
• Gunnar Husebø; Per S. Bakke; Rune Grønseth et al. (2016). Macrophage migration inhibitory factor, a role in COPD. (ekstern lenke)
• Heidi Rolke; Per S. Bakke; Frode Gallefoss (2010). HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer. (ekstern lenke)
• Frode Gallefoss; Per Bakke; IJH Wang et al. (1998). Smokers, highly educated women and stable asthmatics do not want to participate in an asthma school. (ekstern lenke)
• Ida Welle; Geir Egil Eide; Per Bakke et al. (1998). Relationship between single-breath transfer factor for carbon monoxide (TLCO) and airflow obstruction. (ekstern lenke)
• Brian D. Hobbs; Kim De Jong; Maxime Lamontagne et al. (2017). Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1998). Immunglobulin E, virusantistoffer og obstruktiv lungesykdom hos voksne. Forholdet mellom antistoffnivå i serum, lungefunksjon og uspesifikk bronkial reaktivitet. (ekstern lenke)
• Yafang Li; Xiangjun Xiao; Yohan Bossé et al. (2019). Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development. (ekstern lenke)
• Solveig Tangedal; Marianne Aanerud; Louise Jeanette Pauline Persson et al. (2014). Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. (ekstern lenke)
• Inga Cecilie Sørheim; Dawn L. DeMeo; G Washko et al. (2010). Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD. (ekstern lenke)
• Gunnar Gudmundsson; Charlotte Supli Ulrik; Thorarin Gislason et al. (2012). Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. (ekstern lenke)
• Per Bakke; S. Humerfelt; Amund Gulsvik et al. (1992). Astmatiske lungesykdommer. (ekstern lenke)
• Per Bakke; G. OConnor; D. Einarson et al. (1992). Non-specific challenge test for the diagnosis of asthma in a general population sample. (ekstern lenke)
• Amund Gulsvik; Per Bakke; S. Humerfelt et al. (1992). Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. (ekstern lenke)
• Vegard Nilsen; Per S. Bakke; Frode Gallefoss (2011). Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial. (ekstern lenke)
• Inga Cecilie Sørheim; Ane Johannessen; Amund Gulsvik et al. (2010). Gender differences in COPD: are women more susceptible to smoking effects than men?. (ekstern lenke)
• Hester A. Gietema; Lisa D. Edwards; Harvey O. Coxson et al. (2013). Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. (ekstern lenke)
• Heidi Catrine Berg Rolke; Per Bakke; Frode Gallefoss (2008). Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. (ekstern lenke)
• Trude Duelien Skorge; Tomas M.L. Eagan; Geir Egil Eide et al. (2005). The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. (ekstern lenke)
• Trude Duelien Skorge; Tomas M.L. Eagan; Geir Egil Eide et al. (2005). Indoor exposures and respiratory symptoms in a Norwegian community sample. (ekstern lenke)
• Harvey O Coxson; Asger Dirksen; Lisa D Edwards et al. (2013). The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: A prospective analysis from the ECLIPSE study. (ekstern lenke)
• Per Bakke; Ida Welle; Ernst Omenaas et al. (1997). Astma og inneklima i Hordaland. (ekstern lenke)
• Matthew Moll; Joanne E. Sordillo; Auyon J. Ghosh et al. (2023). Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease. (ekstern lenke)
• Bernt Bøgvald Aarli; Peter M.A. Calverley; Robert L. Jensen et al. (2015). Variability of within-breath reactance in COPD patients and its association with dyspnoea. (ekstern lenke)
• Amund Gulsvik; Per Bakke; S. Hummerfelt et al. (1993). Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. (ekstern lenke)
• Linn Tharaldsen Aalstad; Jon Andrew Hardie; Birgitte Espehaug et al. (2018). Lung hyperinflation and functional exercise capacity in patients with COPD - a three-year longitudinal study. (ekstern lenke)
• Tomas Mikal Lind Eagan; Pål Aukrust; Per S. Bakke et al. (2010). Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. (ekstern lenke)
• Tone Smith-Sivertsen; Guri Rørtveit; Amund Gulsvik et al. (2005). Et tverrfaglig undervisningsopplegg om obstruktiv lungesykdom i allmennpraksis. (ekstern lenke)
• P Quist-Paulsen; Per Bakke; Frode Gallefoss (2005). Predictors of smoking cessation in patients admitted for acute coronary heart disease. (ekstern lenke)
• Trine Valaker; Trygve Jonassen; Per Bakke (2005). Røykevaner blant medisinstudenter i Bergen. (ekstern lenke)
• Knut Svanes; JA Søreide; Arne Skarstein et al. (1997). Smoking and ulcer perforation. (ekstern lenke)
• Matthew J. Loza; Ratko Djukanovic; Kian Fan Chung et al. (2016). Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study. (ekstern lenke)
• Bahareh Jouleh; Marta Erdal; Tomas Mikal Eagan et al. (2018). Guideline adherence in hospital recruited and population based COPD patients. (ekstern lenke)
• Sharon M. Lutz; Brittni Frederiksen; Ferdouse Begum et al. (2018). Common and rare variants genetic association analysis of cigarettes per day among ever-smokers in chronic obstructive pulmonary disease cases and controls. (ekstern lenke)
• Amund Gulsvik; Per Bakke; S. Humerfelt et al. (1993). Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. (ekstern lenke)
• Ernst Omenaas; Geir Egil Eide; Per Bakke et al. (1993). Association of airflow impairment to level of serum IgE and number of respiratory virus antibodies in subsamples of a general population. (ekstern lenke)
• Johanna Maria Samulin-Erdem; Vidar Skaug; Per S. Bakke et al. (2016). Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. (ekstern lenke)
• Akkelies E. Dijkstra; J Smolonska; M Van Den Berge et al. (2014). Susceptibility to chronic mucus hypersecretion, a genome wide association study. (ekstern lenke)
• Pere Almagro; Pablo Martínez-Camblor; Marc Miravitlles et al. (2019). External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study. (ekstern lenke)
• Vasileios Andrianopoulos; Emiel F.M. Wouters; Victor M. Pinto-Plata et al. (2015). Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. (ekstern lenke)
• Marie Johanne Wåtevik; Ane Johannessen; Francisco Gomez Real et al. (2016). Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD patients.. (ekstern lenke)
• Tomas M Eagan; Amund Gulsvik; Geir Egil Eide et al. (2002). Occupational airborne exposure and the incidence of respiratory symptoms and asthma. (ekstern lenke)
• Tomas M Eagan; Per Bakke; Geir Egil Eide et al. (2002). Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. (ekstern lenke)
• Frode Gallefoss; Per Bakke (2002). Effekter av astmaopplæring i en randomisert, kontrollert undersøkelse. (ekstern lenke)
• Frode Gallefoss; Per Bakke (2002). Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. (ekstern lenke)
• Paul Brinkman; Ariane H. Wagener; Pieter-Paul Hekking et al. (2019). Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma. (ekstern lenke)
• Valentyna Yasinska; Cristina Gómez; Johan Kolmert et al. (2023). Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids. (ekstern lenke)
• Tone Smith-Sivertsen; Guri Rørtveit; Amund Gulsvik et al. (2006). Obstruktiv lungesykdom hos barn og voksne. Presentasjon av et integrert undervisningsopplegg i allmennmedisin. (ekstern lenke)
• Nick Shrine; Anna L. Guyatt; A. Mesut Erzurumluoglu et al. (2019). New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. (ekstern lenke)
• Fazian Aminuddin; Loubna Akhabir; Dorota Stefanowicz et al. (2012). Genetic association between human chitinases and lung function in COPD. (ekstern lenke)
• Sreekumar G. Pillai; Dongliang Ge; Guohua Zhu et al. (2009). A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. (ekstern lenke)
• Inga Cecilie Sørheim; Ane Johannessen; Thomas Grydeland et al. (2010). Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results?. (ekstern lenke)
• Eirunn Waatevik Saure; Per S. Bakke; Tomas Mikal Eagan et al. (2016). Diffusion capacity and CT measures of emphysema and airway wall thickness – relation to arterial oxygen tension in COPD patients.. (ekstern lenke)
• Tomas M Eagan; Geir Egil Eide; Amund Gulsvik et al. (2002). Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. (ekstern lenke)
• Elin Tollefsen; B. Midgren; Per S. Bakke et al. (2010). Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. (ekstern lenke)
• Andreas Thelle; Miriam Gjerdevik; Thomas Blix Grydeland et al. (2015). Pneumothorax size measurements on digital chest radiographs: Intra- and inter- rater reliability. (ekstern lenke)
• Jörgen Östling; Marleen van Geest; James P.R. Schofield et al. (2019). IL-17-high asthma with features of a psoriasis immunophenotype. (ekstern lenke)
• Tone Smith-Sivertsen; Esperanza Diaz; Dan Pope et al. (2009). Effect of reducing indoor air pollution on women’s respiratory symptoms and lung function: The RESPIRE Randomized Trial, Guatemala. (ekstern lenke)
• Peter J. Castaldi; Michael H. Cho; Augusto A. Litonjua et al. (2011). The Association of Genome-Wide Significant Spirometric Loci with Chronic Obstructive Pulmonary Disease Susceptibility. (ekstern lenke)
• Peter J. Castaldi; Michael H. Cho; Xiaobo Zhou et al. (2015). Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci. (ekstern lenke)
• Marianne Aanerud; Harald Braut; Tore Wentzel-Larsen et al. (2013). Non-response in telephone surveys of COPD patients does not introduce bias. (ekstern lenke)
• Knut Svanes; JA Søreide; Arne Skarstein et al. (1997). Smoking and ulcer perforation. (ekstern lenke)
• Yusef Eamon Badi; Ana B. Pavel; Stelios Pavlidis et al. (2022). Mapping atopic dermatitis and anti–IL-22 response signatures to type 2–low severe neutrophilic asthma. (ekstern lenke)
• Kentaro Takahashi; Stelios Pavlidis; Francois Ng Kee Kwong et al. (2018). Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: An exploratory analysis. (ekstern lenke)
• Vegard Nilsen; Per S. Bakke; Gudrun-Elin Rohde et al. (2015). Is sense of coherence a predictor of lifestyle changes in subjects at risk for type 2 diabetes?. (ekstern lenke)
• Tomas Mikal Lind Eagan; Pål Aukrust; Thor Ueland et al. (2010). Body composition and plasma levels of inflammatory biomarkers in COPD. (ekstern lenke)
• Ernst Omenaas; Per Bakke; E. Eide et al. (1995). Total serum IgE and FEV%b by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1995). Husstøvmidd sensibilisering: gir det nedsatt lungefunksjon og økt bronkial aktivitet hos voksne?. (ekstern lenke)
• Ane Aamli Gagnat; Miriam Gjerdevik; Frode Gallefoss et al. (2017). Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: A community-based cohort. (ekstern lenke)
• Amund Gulsvik; Per Bakke; Jan Brøgger et al. (2020). Respiratory symptoms and mortality in four general population cohorts over 45 years. (ekstern lenke)
• Solveig Tangedal; Marianne Aanerud; Rune Grønseth et al. (2017). Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. (ekstern lenke)
• Louise Persson; Marianne Aanerud; Pieter Sicco Hiemstra et al. (2012). Chronic obstructive pulmonary disease is associated with low levels of vitamin D. (ekstern lenke)
• Janwillem Kocks; António Jorge Ferreira; Per S. Bakke et al. (2023). Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study. (ekstern lenke)
• Ernst Omenaas; Per Bakke; Geir Egil Eide et al. (1995). Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. (ekstern lenke)
• Guohua Zhu; Per S. Bakke; Amund Gulsvik et al. (2009). Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. (ekstern lenke)
• Inga Cecilie Sørheim; Ane Johannessen; Thomas Grydeland et al. (2009). Case–control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results?. (ekstern lenke)
• Neda Farahi; Ellie Paige; Jozef Balla et al. (2017). Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Hanna Sandelowsky; Anders Løkke; Janwillem W.H. Kocks et al. (2025). The Burden of COPD with Type 2 Inflammation in North-West Continental Europe. (ekstern lenke)
• Tomas M.L. Eagan; Jan Christian Brøgger; Geir Egil Eide et al. (2005). The incidence of adult asthma: a review. (ekstern lenke)
• Inga Cecilie Sørheim; Amund Gulsvik; Per S. Bakke et al. (2009). Genetikk ved kronisk obstruktiv lungesykdom. (ekstern lenke)
• Jørgen Vestbo; Alvar Agusti; Emiel F.M. Wouters et al. (2014). Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. (ekstern lenke)
• Einar Marius Hjellestad Martinsen; Elise Orvedal Leiten; Per S. Bakke et al. (2016). Participation in research bronchoscopy: a literature review. (ekstern lenke)
• Elise Orvedal Leiten; Einar Marius Hjellestad Martinsen; Tomas Mikal Eagan et al. (2016). Complications and discomfort of bronchoscopy: a systematic review. (ekstern lenke)
• Rosa Faner; Ruth Tal-Singer; John H. Riley et al. (2014). Lessons from ECLIPSE: A review of COPD biomarkers. (ekstern lenke)
• Dominic Burg; James P.R. Schofield; Joost Brandsma et al. (2018). Large-scale label-free quantitative mapping of the sputum proteome. (ekstern lenke)

Leserbrev

• Amund Gulsvik; Per S. Bakke; Knut Stavem (2025). Nordic Respiratory Academy: a historical note and reflection. (ekstern lenke)
• Per S. Bakke; Eva Rönmark; Tomas Mikal Eagan et al. (2012). Recommendations for epidemiological studies on COPD. (ekstern lenke)
• Andreas Thelle; Per S. Bakke (2017). Needle aspiration should be considered as primary intervention option for stable patients with spontaneous pneumothorax. (ekstern lenke)
• Sverre Lehmann; J Grebstad; O Fondenes et al. (2005). Behandling av obstruktiv søvnapné. (ekstern lenke)
• Thomas Grydeland; P Methlie; Per Bakke (2005). Hospital doctors' and nurses' knowledge of how to use inhalation devices correctly. (ekstern lenke)
• Andrew J. Simpson; Pieter-Paul Hekking; Dominic E. Shaw et al. (2018). Treatable traits in the European U-BIOPRED adult asthma cohorts. (ekstern lenke)
• IC Sorheim; A Johannessen; A Gulsvik et al. (2011). Gender differences in COPD: are women more susceptible to smoking effects than men? Response. (ekstern lenke)
• Jeanne-Marie Perotin; James P.R. Schofield; Susan J. Wilson et al. (2019). Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux. (ekstern lenke)
• Ane Johannessen; Sverre Lehmann; Ernst Omenaas et al. (2007). Defining the lower limit of normal for FEV1/FVC - From the authors. (ekstern lenke)

Konferanseabstrakt

• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2016). Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD. (ekstern lenke)
• Linn Tharaldsen Aalstad; Jon Andrew Hardie; Einar Thorsen et al. (2017). Static hyperinflation and decline in functional capacity in COPD patients. (ekstern lenke)
• Heidi Catrine Berg Rolke; Per S. Bakke; Frode Gallefoss (2007). Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. (ekstern lenke)
• Tone Smith-Sivertsen; Nigel Bruce; Anaite Diaz et al. (2004). Chronic airway symptoms and lung function among women in a rural community in Guatemala with high indoor air pollution levels. (ekstern lenke)
• Ingvild Haaland; Marit Elisabeth Aardal; Frode Steingrimsen Berven et al. (2020). Changes in the induced sputum proteome during COPD exacerbations. (ekstern lenke)
• Peter J. Lipman; Michael H. Cho; Per S. Bakke et al. (2010). Testing for Weak Signal. (ekstern lenke)
• Bahareh Jouleh; Ingvild Haaland; Fahimeh Khorsand et al. (2020). Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD. (ekstern lenke)
• Ingvild Haaland; Solveig Tangedal; Rune Nielsen et al. (2019). Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels. (ekstern lenke)
• Rune Nielsen; Anne-Kristin M Johannessen; Per S. Bakke et al. (2009). How expensive is comorbidity in COPD?. (ekstern lenke)
• Kia Minna Johanna Hynninen; Ståle Pallesen; Nina Bjerke et al. (2007). Cognitive behavioural therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease. (ekstern lenke)
• Tor H. Qvale; Anette Storstein; Kibret Yimer Mazengia et al. (2012). Hu antibodies are present in smokers with chronic obstructive pulmonary disease without cancer or neurological disease. (ekstern lenke)
• Minna Hynninen; Nina Bjerke; Ståle Pallesen et al. (2008). Group cognitive behavioural therapy for anxiety, depression and sleep disturbances in patients with chronic respiratory illness. (ekstern lenke)
• Rune Nielsen; Yaxin Xue; Inge Jonassen et al. (2019). Repeated bronchoscopy examination of the airway microbiome. (ekstern lenke)
• Ingvild Haaland; Marianne Aanerud; Solveig Tangedal et al. (2014). Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. (ekstern lenke)

Vitenskapelig bokkapittel

• Amund Gulsvik; Per Bakke; S. Humerfelt et al. (1994). Spirometry and transfer factor for carbon monoxide in asymptomatic never smokers from a general population. (ekstern lenke)
• Amund Gulsvik; Per Bakke (1997). Farmakoterapi ved lunge- og luftveissykdommer. (ekstern lenke)
• Per Bakke; K Katsouyanni; L Carrozzi (2000). Study design. (ekstern lenke)

Konferanseforedrag

• Trude Duelien Skorge; Tomas M.L. Eagan; Geir Egil Eide et al. (2004). Indoor air pollutions and respiratory symptoms in a Norwegian community sample. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2002). Long term changes in self-reported symptoms and diagnoses of obstructive lung disease and heart disease in Oslo, Norway. (ekstern lenke)
• Marie Waatevik; Tomas Mikal Eagan; Jon Andrew Hardie et al. (2017). Repeated desaturation in 6 minute walk test increases risk for mortality in COPD patients. (ekstern lenke)
• Ane Johannessen; Per Bakke; Ernst Omenaas et al. (2002). Prevalence and seveity of GOLD defined COPD in adults. (ekstern lenke)
• Susanne Hernes; Egil Hagen; Bjarne Bjorvatn et al. (2007). Virale pneumonier hos eldre. (ekstern lenke)
• Kia Minna Johanna Hynninen; Ståle Pallesen; Nina Bjerke et al. (2007). Cognitive behavioral therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease. (ekstern lenke)
• O Fondenes; Ernst Omenaas; Per Bakke et al. (1999). The risks of snoring and day-time hypersomnolence in a general Norwegian population. Poster. (ekstern lenke)
• Trude Duelien; Tomas M Eagan; Amund Gulsvik et al. (2003). The association between indoor climate and respiratory symptoms in a general population sample. (ekstern lenke)
• Inger Hilde Nordhus; Kia Minna Johanna Hynninen; Ståle Pallesen et al. (2008). Cognitive behavioural therapy (CBT) for anxiety and depression in COPD: A treatment option in pulmonary care. (ekstern lenke)

Konferanseposter

• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2014). Dynamic hyperinflation and respiratory timing during incremental exercise in patients with chronic obstructive pulmonary disease. (ekstern lenke)
• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2014). Longitudinal change in peak oxygen uptake in COPD patients. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2002). Increasing incidence of self-reported asthma in adults in Norway. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2002). Changes in occupational exposure as a risk factor for obstructive lung disease. (ekstern lenke)
• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2014). Longitudinal change in peak oxygen uptake in COPD patients. (ekstern lenke)
• Marianne Aanerud; T Wentzel-Larsen; Jan Christian Brøgger et al. (2002). Quality of life varies by gender, age, smoking and educational level in a Norwegian general population. (ekstern lenke)
• Vegard Nilsen; Gudrun-Elin Rohde; Per S. Bakke et al. (2013). Is mastery a predictor for lifestyle changes in subjects at risk for type 2 diabetes?. (ekstern lenke)
• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2012). Predictors for longitudinal change in 6-Minute Walk Distance in COPD patients. (ekstern lenke)
• Kia Minna Johanna Hynninen; Nina Bjerke; Ståle Pallesen et al. (2007). Group CBT for anxiety and depression in patients with a chronic somatic illness. (ekstern lenke)
• Trude Duelien; Tomas M Eagan; Geir Egil Eide et al. (2004). Indoor air pollutions and respiratory symptoms in a Norwegian community sample. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2001). Increasing incidence of asthma in Norway. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2001). Increase in hay fever and occupational exposure to dusts or gases in adults in Norway. (ekstern lenke)
• Tomas M Eagan; Amund Gulsvik; Geir Egil Eide et al. (2003). Socioeconomic Status Is an Independent Predictor of the Incidence of Respiratory Symptoms and Asthma. (ekstern lenke)
• Rune Nielsen; Per Bakke; Ane Johannessen et al. (2005). Airflow obstruction is associated with increased health care utilization in self-reported obstructive lung disease. (ekstern lenke)
• Ane Johannessen; Sverre Lehmann; Ernst Omenaas et al. (2005). Strategy for selecting a spirometric reference population. (ekstern lenke)
• Bente Frisk; Birgitte Espehaug; Jon Andrew Hardie et al. (2013). Slope and curvature of the relationship between ventilation and tidal volume in COPD patients. (ekstern lenke)
• Tone Smith-Sivertsen; Nigel Bruce; Anaite Diaz et al. (2004). Chronic Airway Symptoms And Lung Function Among Women In A Rural Community In Guatemala With High Indoor Air Pollution Levels. (ekstern lenke)
• Tomas M. Eagan; Per Bakke; Geir Egil Eide et al. (2000). Predictors and consequences of non-response in an 11 years cohort study. (ekstern lenke)
• Amund Gulsvik; Jan Brøgger; Per Bakke et al. (2000). Asthma and weezing are increasing in repeated community surveys of adults. (ekstern lenke)
• Tomas Eagan; Per Bakke; Geir Egil Eide et al. (2000). Remission of morning cough is six times higher in those giving up smoking. (ekstern lenke)
• Jan Brøgger; Per Bakke; Geir Egil Eide et al. (2000). Response rate does not affect prevalence and risk factors of asthma-like symptoms in a Norwegian community survey. (ekstern lenke)
• B Lundbäck; L Carrozzi; Per Bakke et al. (2000). Bronchitic symptoms and their relation to FEV. (ekstern lenke)
• Trude Duelien Skorge; Tomas Mikal Lind Eagan; Geir Egil Eide et al. (2007). JEM-based occupational exposure assessment and incidence of respiratory disorders in a community sample. (ekstern lenke)
• Ane Johannessen; Per Bakke; Ernst Omenaas et al. (2002). Incidence of COPD in a Norwegian community. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2001). Increase in hay fever and occupational exposure to dust and gases in repeated population surveys in Norway. (ekstern lenke)
• T. M. L. Eagan; Per Bakke; G. E. Eide et al. (2001). Does previous exposure to occupational dust or gas give increased incidence of respiratory symptoms and asthma ?. (ekstern lenke)
• T. M. L. Eagan; Per Bakke; G. E. Eide (2001). The incidence of respiratory symptoms and asthma by occupational airborne exposure in a community sample. (ekstern lenke)
• Bernt Bøgvald Aarli; Peter Calverley; Tomas Mikal Eagan et al. (2010). Reference values for resistance and reactance measures from Impuls Oscillometry in healthy elderly. (ekstern lenke)
• Bernt Bøgvald Aarli; Robert L. Jensen; Tomas Mikal Eagan et al. (2009). Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD. (ekstern lenke)
• Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2012). Exacebation history in COPD patients with and without expiratory flow limitation (EFL).. (ekstern lenke)
• Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2014). Mortality In COPD Patients With Increased Intrabreath Reactance. (ekstern lenke)
• Bernt Bøgvald Aarli; Peter MA Calverley; Tomas Mikal Eagan et al. (2014). Flow limitation during resting breathing is associated with reduced exercise capability in COPD.. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2001). Increasing incidence of asthma in Norway. (ekstern lenke)
• Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2011). Expiratory flow limitation (EFL) detected non-invasively as a phenotypic characteristic of COPD. (ekstern lenke)
• Bernt Bøgvald Aarli; Peter MA Calverley; Xavier Soler et al. (2016). Longitudinal changes in Peak Oxygen Uptake in Chronic Obstructive Pulmonary Disease (COPD) Patients with Dynamic Hyperinflation and/or Tidal Expiratory Flow Limitation. (ekstern lenke)
• Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2012). Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-invasively By Impulse Oscillometry. (ekstern lenke)
• Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2013). Can intra-breath variations of reactance predict dyspnea?. (ekstern lenke)
• Susanne Hernes; Egil Hagen; Hanne Quarsten et al. (2011). Testing For Respiratory Viruses In The Elderly,- Does It Really Matter?. (ekstern lenke)
• Susanne Hernes; Niels Thomas Finsen; Egil Hagen et al. (2007). Transthoracic fine needle aspiration is a safe and well-tolerated method for etiological diagnosis of community-acquired pneumonia. (ekstern lenke)
• Jan Brøgger; Per Bakke; Geir Egil Eide et al. (1999). Comparison between two respiratory symptom questionaires, by sex, age and smoking habits. Poster. (ekstern lenke)
• Tomas Eagan; Per Bakke; Ida Welle et al. (1999). Incidence and remission rates of respiratory symptoms by sex, age and smoking in a Norwegian community during twelve years. Poster. (ekstern lenke)
• Anne Edvardsen; Aina Akerø; Tomas Mikal Lind Eagan et al. (2010). In-flight respiratory symptoms and pre-flight characteristics in patients with COPD. (ekstern lenke)
• Geir Egil Eide; O Gefeller; M Land et al. (1999). New epidemiological interpretations of the average attributable fraction from a game theoretical perspective. Poster. (ekstern lenke)
• Ida Welle; Per Bakke; Geir Egil Eide et al. (1999). Relationship between two biological inflammatory markers and single-breath transfer factor for carbon monoxide (TLCO) in a general population sample. Abstract of poster P906. (ekstern lenke)
• Ane Johannessen; Ernst Omenaas; Per Bakke et al. (2004). Prevalence of chronic obstructive pulmonary disease in a Western Norwegian community - a comparison of spirometric disease criteria. (ekstern lenke)
• Ane Johannessen; Ernst Omenaas; Per Bakke et al. (2004). Prevalence and risk factors of spirometric defined chronic obstructive pulmonary disease in a Norwegian community. (ekstern lenke)
• Jan Brøgger; Per Bakke; Geir Egil Eide et al. (2002). Increasing Incidence Of Self-Reported Asthma In Adults In Norway. In Final Program: [C28] [Poster: 707]. (ekstern lenke)
• B Lundbäck; L Carrozzi; Per Bakke et al. (2000). Bronchitic symptoms and their relation to FEV. (ekstern lenke)
• Tomas M Eagan; Per Bakke; Geir Egil Eide et al. (2000). Predictors and consequences of non-response in an 11 years cohort study. (ekstern lenke)
• Amund Gulsvik; Jan Christian Brøgger; Per Bakke et al. (2000). Asthma and weezing are increasing in repeated community surveys of adults. (ekstern lenke)
• Tomas M Eagan; Per Bakke; Geir Egil Eide et al. (2000). Remission of morning cough is six times higher in those giving up smoking. (ekstern lenke)
• Jan Christian Brøgger; Per Bakke; Geir Egil Eide et al. (2000). Response rate does not affect prevalence and risk factors of asthma-like symptoms in a Norwegian community survey. (ekstern lenke)
• Jon Andrew Hardie; A. Sonia Buist; William M Vollmer et al. (2002). Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. (ekstern lenke)
• Bente Frisk; Jon Andrew Hardie; Birgitte Espehaug et al. (2015). Peak oxygen uptake and breathing pattern in COPD patients – a four year longitudinal study. (ekstern lenke)
• Anne Edvardsen; Aina Akerø; Tomas Mikal Lind Eagan et al. (2010). Air travel habits in patients with COPD. (ekstern lenke)

Rettelse i tidsskrift

• Nick Shrine; Abril G. Izquierdo; Jing Chen et al. (2023). Author Correction: Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk (Nature Genetics, (2023), 55, 3, (410-422), 10.1038/s41588-023-01314-0). (ekstern lenke)
• Nick Shrine; Anna L. Guyatt; A. Mesut Erzurumluoglu et al. (2024). Correction to: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries (Nature Genetics, (2019), 51, 3, (481-493), 10.1038/s41588-018-0321-7). (ekstern lenke)
• Nick Shrine; Anna L. Guyatt; A. Mesut Erzurumluoglu et al. (2019). Author Correction: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries (Nature Genetics, (2019), 51, 3, (481-493), 10.1038/s41588-018-0321-7). (ekstern lenke)

Fremhevet artikkel i media

• Amund Gulsvik; Per Bakke (1995). Luftforurensning i innemiljø og sykdommer i lunger og luftveier. (ekstern lenke)
• Per Bakke; R. Hanoa; Amund Gulsvik (1992). Obstruktiv lungesykdom i en norsk befolkning - Risikofaktorer og forekomst. (ekstern lenke)
• Per S. Bakke; Kristian Jong Høines; Frode Gallefoss (2024). Kols – kan vi redusere dødeligheten med medikamenter?. (ekstern lenke)
• Per Bakke; Amund Gulsvik (2001). Lungescreening: Kan gi grønt lys for røykere. (ekstern lenke)
• Per Bakke; S Humerfelt (1995). Lungehelse hos bønder. (ekstern lenke)
• Per Bakke (1990). Bokanmeldelse: Rasmussen FV: Lungefunktion, boligforhold, erverv og rygevaner. (ekstern lenke)
• Per Bakke (1990). Bokanmeldelse: Mygind N, Pipkorn U, Dahl R (red): Rhinitis and asthma similarities and differences. (ekstern lenke)

Lederartikkel

• Per S. Bakke (2010). Non-response in epidemiological studies - How to cope with it?. (ekstern lenke)
• Anne Lindberg; Per S. Bakke; Johann Christian Virchow et al. (2018). The impact of exacerbations among subjects with COPD, what can we learn from 'big data'?. (ekstern lenke)
• Per S. Bakke (2009). Non-response in epidemiological studies - How to cope with it?. (ekstern lenke)

Forskningsrapport

• Per Bakke; Lars Fredrik Svendsen; N. P. Boye et al. (1990). Bronkial reaktivitet i en norsk befolkning. (ekstern lenke)
• Inger Ariansen; Wenche Nystad; Sidsel Graff-Iversen et al. (2017). Utvikling av indikatorer på NCD området knyttet til rapportering for den globale og nasjonale NCD strategien. (ekstern lenke)

Populærvitenskapelig artikkel

• Ane Johannessen; Per Bakke; Tomas M Eagan et al. (2006). Astma og KOLS i en generell voksen befolkning i Vest-Norge. (ekstern lenke)

Doktorgradsavhandling

• Tomas M. Eagan; Per Bakke (2004). Incidence and remission of asthma and respiratory symptoms in adults: The Hordaland County Cohort Study. (ekstern lenke)
• Michael Langballe Storebø; Einar Thorsen; Per S. Bakke (2019). Diffusing capacity of the lung for carbon monoxide. Variability and longitudinal changes over nine years. (ekstern lenke)
• Heidi Catrine Berg Rolke; Per S. Bakke; Frode Gallefoss (2009). Lung cancer in Agder counties in Southern Norway - results from a three year unselected inclusion of patients with newly diagnosed lung cancer. (ekstern lenke)
• Marianne Voll-Aanerud; Per S. Bakke (2009). The association of respiratory symptoms and health-related quality of life in the general population : the Hordaland County Cohort Study and the European Community Respiratory Health Survey. (ekstern lenke)
• Bernt Bøgvald Aarli; Jon Andrew Hardie; Tomas Mikal Eagan et al. (2018). Tidal Expiratory Flow Limitation. A new method for evaluating pulmonary function in elderly and patients with Chronic Obstructive Pulmonary Disease. (ekstern lenke)
• Petter Quist-Paulsen; Frode Gallefoss; Per Bakke (2007). The effects of smoking cessation intervention in patients with coronary heart disease : a randomised controlled trial. (ekstern lenke)
• Per Bakke (1992). Obstructive airway diseases and occupational airborne exposure prevalences and risk factors in a Norwegian community. (ekstern lenke)

Fagbok

• Amund Gulsvik; Per Bakke (2004). Lungesykdommer. En basal innføring. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.